Intracellular ATP Concentration Contributes to the Cytotoxic and Cytoprotective Effects of Adenosine

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Li, Shujue ^a   Li, Xiaofen ^a   Guo, Haiping ^a   Liu, Shouting ^a   Huang, Hongbiao ^a   Liu, Ningning ^a   Yang, Changshan ^a   Tang, Ping ^a   Liu, Jinbao ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; PROTEASOME;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DENSITY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; NONHUMAN; PROTEIN CONTENT; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOSINE; ADENOSINE TRIPHOSPHATE; BIOLOGICAL TRANSPORT; CELL DEATH; CELL SURVIVAL; CYTOPROTECTION; CYTOSOL; CYTOTOXINS; GENE EXPRESSION; HUMANS; K562 CELLS; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 84884891344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076731     Document Type: Article

References (35)

1. Schrier SM, van Tilburg EW, van der Meulen H, Ljzerman AP, Mulder GJ, (2001) Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. Biochem Pharmacol. 61: 417-425.
2. Ethier MF, Chander V, Dobson JG Jr, (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol. 265: H131-138.
3. Ethier MF, Dobson JG Jr, (1997) Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Physiol. 272: H1470-1479.
4. Fishman P, Bar-Yehuda S, Vagman L, (1998) Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res. 58: 3181-3187.
5. Kohno Y, Sei Y, Koshiba M, Kim HO, Jacobson KA, (1996) Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. Biochem Biophys Res Commun. 219: 904-910.
6. Shneyvays V, Jacobson KA, Li AH, Nawrath H, Zinman T, et al. (2000) Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Exp Cell Res. 257: 111-126.
7. Ramkumar V, Hallam DM, Nie Z, (2001) Adenosine, oxidative stress and cytoprotection. Jpn. J. Pharmacol. 86: 265-274.
8. Bes S, Ponsard B, Asri MEl, Tissier C, Vandroux D, et al. (2002) Assessment of the cytoprotective role of adenosine in an in vitro cellular model of myocardial ischemia. Eur J Pharmacol. 452: 145-154.
9. Duranski MR, Greer JJ, Dejam A, Jaqanmohan S, Hogg N, et al. (2005) Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 115: 1232-1240.
10. Barankiewicz J, Danks AM, Abushanab E, Makings L, Wiemann T, et al. (1997) Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors. J Pharmacol Exp Ther. 283: 1230-1238.
11. Jacobson KA, (1998) Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci. 19: 184-191.
12. Imura T, Shimohama S, (2000) Opposing effects of adenosine on the survival of glial cells exposed to chemical ischemia. J Neurosci Res. 62: 539-546.
13. Merighi S, Mirandola P, Milani D, Varani K, Gessi S, et al. (2002) Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol. 119: 923-933.
14. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J, (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 53: 527-552.
15. Huang H, Zhang X, Li S, Liu N, Lian W, et al. (2010) Physiological levels of ATP negatively regulate proteasome function. Cell Res. 20: 1372-1385.
16. Huang H, Liu N, Guo H, Liao S, Li X, et al. (2012) L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro. PLoS One 7: e49062.
17. Li X, Liu S, Huang H, Liu N, Zhao C, et al. (2013) Gambogic Acid is a Tissue-Specific Proteasome Inhibitor in vitro and in vivo. Cell reports. 3: 211-222.
18. Eguchi Y, Shimizu S, Tsujimoto Y, (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57: 1835-1840.
19. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P, (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 185: 1481-1486.
20. Pearson JD, Carleton JS, Hutchings A, Gorden JL, (1978) Uptake and metabolism of adenosine by pig aortic endothelial and smooth-muscle cells in culture. Biochem J. 170: 265-271.
21. Gu JG, Nath A, Geiger JD, (1996) Characterization of inhibitor-sensitive and-resistant adenosine transporters in cultured human fetal astrocytes. J. Neurochem. 67: 972-977.
22. Fozard JR, Carruthers AM, (1993) Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol. 109: 3-5.
23. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, et al. (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65: 613-621.
24. Hsu PP, Sabatini DM, (2008) Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
25. Rapaport E, (1980) Compartmentalized ATP pools produced from adenosine are nuclear pools. J Cell Physiol. 105: 267-274.
26. Rapaport E, Zamecnik PC, (1976) Incorporation of adenosine into ATP: formation of compartmentalized ATP. Proc Natl Acad Sci U S A. 73: 3122-3125.
27. Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, et al. (2001) The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res. 269: 230-236.
28. Livingston M, Heaney LG, Ennis M, (2004) Adenosine, inflammation and asthma-a review. Inflamm Res. 53: 171-178.
29. Abbracchio MP, Brambilla R, Ceruti S, Kim HO, von Lubitz DK, et al. (1995) G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol Pharmacol. 48: 1038-1045.
30. Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, et al. (1997) Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med. 186: 1615-1620.
31. Gao Z, Li BS, Day YJ, Linden J, (2001) A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol. 59: 76-82.
32. Baharav E, Bar-Yehuda S, Madi L, Silberman D, Rath-Wolfson L, et al. (2005) Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models. J Rheumatol. 32: 469-476.
33. Ongini E, Schubert P, (1998) Neuroprotection induced by stimulating A1 or blocking A2A adenosine receptors: an apparent paradox. Drug Dev Res. 45: 387-393.
34. Apasov S, Chen JF, Smith P, Sitkovsky M, (2000) A(2A) receptor dependent and A(2A) receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood 95: 3859-3867.
35. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, et al. (2000) A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol. 279: F809-818.